Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With miracle drugs within reach, they write that they are aghast at funding cuts… ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...

LONDON (AP) -- The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.

Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, Yeztugo. Read more here.

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission. In a statement on ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV.

Commentary Comment: Cuts to federal HIV funding amount to negligence Loss of treatment and prevention tools will mean more lives lost and greater health care costs. Friday, July 25, 2025 1:30am ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...

UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences. A new artificial intelligence model can improve the process of drug and vaccine discovery by ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a recent licensing agreement ensuring accelerated access to countries in need.